Legal & General Group
HZNP

Legal & General Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Legal & General Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,059
Closed -$2.9M – 3421
2023
Q3 		$2.9M Sell
25,059
-817
-3% -$87.8K ﹤0.01% 1726
2023
Q2 		$2.66M Buy
+25,876
New +$2.73M ﹤0.01% 1783
2023
Q1 		– Sell
-31,776
Closed -$3.62M – 3442
2022
Q4 		$3.62M Buy
31,776
+5,133
+19% +$426K ﹤0.01% 1590
2022
Q3 		$1.65M Buy
26,643
+7,521
+39% +$526K ﹤0.01% 1957
2022
Q2 		$1.52M Sell
19,122
-2,388
-11% -$226K ﹤0.01% 2012
2022
Q1 		$2.26M Buy
21,510
+9,634
+81% +$939K ﹤0.01% 1936
2021
Q4 		$1.28M Buy
11,876
+1,335
+13% +$146K ﹤0.01% 2184
2021
Q3 		$1.16M Sell
10,541
-10,599
-50% -$1.1M ﹤0.01% 2207
2021
Q2 		$1.98M Sell
21,140
-1,217
-5% -$112K ﹤0.01% 1977
2021
Q1 		$2.06M Buy
22,357
+635
+3% +$53.6K ﹤0.01% 1971
2020
Q4 		$1.59M Buy
21,722
+2,261
+12% +$168K ﹤0.01% 1980
2020
Q3 		$1.51M Sell
19,461
-3,493
-15% -$240K ﹤0.01% 1884
2020
Q2 		$1.28M Buy
22,954
+15,805
+221% +$676K ﹤0.01% 1902
2020
Q1 		$258K Sell
7,149
-2,593
-27% -$87.7K ﹤0.01% 2231
2019
Q4 		$353K Buy
9,742
+276
+3% +$8.46K ﹤0.01% 2290
2019
Q3 		$241K Buy
9,466
+186
+2% +$4.81K ﹤0.01% 2315
2019
Q2 		$223K Sell
9,280
-77,138
-89% -$1.96M ﹤0.01% 2325
2019
Q1 		$2.28M Buy
86,418
+12,732
+17% +$302K ﹤0.01% 1644
2018
Q4 		$1.44M Buy
73,686
+6,054
+9% +$119K ﹤0.01% 1738
2018
Q3 		$1.32M Buy
67,632
+10,121
+18% +$192K ﹤0.01% 1868
2018
Q2 		$952K Sell
57,511
-3,558
-6% -$54.3K ﹤0.01% 1937
2018
Q1 		$867K Sell
61,069
-11,070
-15% -$164K ﹤0.01% 1940
2017
Q4 		$1.06M Buy
72,139
+8,296
+13% +$117K ﹤0.01% 1868
2017
Q3 		$809K Buy
63,843
+7,291
+13% +$92.7K ﹤0.01% 1953
2017
Q2 		$669K Buy
56,552
+2,282
+4% +$28.4K ﹤0.01% 1972
2017
Q1 		$806K Sell
54,270
-744
-1% -$12K ﹤0.01% 1874
2016
Q4 		$890K Buy
+55,014
New +$998K ﹤0.01% 1782

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legal & General Group's HZNP Position: Q4 2023 in Review

Legal & General Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 25,059 shares — an estimated $2.9M sold.

Legal & General Group first reported a position in HZNP in Q4 2016 and held it in 27 quarters. The position peaked at $3.62M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Legal & General Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Legal & General Group sold 25,059 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.9M.
  • Legal & General Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 27 quarters.
  • Legal & General Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.62M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Legal & General Group's 13F filing for Q4 2023, filed 15 Feb 2024.